- Home
- Chronic Conditions
- Asthma/COPD
- AirFluSal MDI
AirFluSal MDI
Images for illustrative purposes only
AirFluSal MDI is a combination inhalation treatment used for the long-term management of asthma and chronic obstructive pulmonary disease (COPD) containing the active ingredients salmeterol and fluticasone propionate.
- Contains both a preventer steroid and a long-acting bronchodilator for dual-action airway management
- Designed to provide continuous respiratory support for up to 12 hours with regular use
- A widely prescribed MDI (Metered Dose Inhaler) used across the NHS for chronic asthma and COPD
- Fulfilled by Mail my Meds and delivered discreetly to your door following a clinical review
In Stock
Discreet Packaging
Prescription included
Quick & Easy

